Docetaxel and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Cancer |
Cho Eun-Hee
(Department of Internal Medicine, Seoul Veterans Hospital)
Cho Keun-Hyok (Department of Internal Medicine, Seoul Veterans Hospital) Song Young-Bong (Department of Internal Medicine, Seoul Veterans Hospital) Choi Ik-Sung (Department of Internal Medicine, Seoul Veterans Hospital) Choi Jae-Won (Department of Internal Medicine, Seoul Veterans Hospital) Nam Seung-Hyun (Department of Internal Medicine, Seoul Veterans Hospital) Kim Bong-Seog (Department of Internal Medicine, Seoul Veterans Hospital) |
1 | Ervin TJ, Clark JR, Weichselbaum RR: Multidisciplinary treatment of advanced squamous carcinoma of the head and neck. Semin Oncol. 1985;12 (4 Suppl 6):71-78 |
2 | Wittes R, Heller K, Randolph V, et al: Cis-diamminedichloroplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer. Cancer Treat Rep. 1979;63:1533-1538 |
3 | Kim HK, Han JY, Kang JH, et al: Induction chemotherapy using 5-FU and cisplatin and radiotherapy in patients with locally advanced head and neck cancer. Korean J Medicine. 1995:49: 484-491 |
4 | Weaver A, Flemming S, Kish J, et al: Cis-platinum and 5-Fluorouracil as induction therapy for advanced head and neck cancer. Am J Surg. 1982;144:445-448 DOI ScienceOn |
5 | Park JH, Choi HS, Kim JH, et al: Neoadjuvant chemotherapy with 5-fluorouracil and cisplatin for locally advanced head and neck cancer. J Korean Cancer Assoc. 1995;27:990-1001 |
6 | Forastiere A, Glisson B, Murphy B, O'Connell B: A Phase II study of docetaxel and cisplatin in patients with locally advanced, recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN), not curable by standard therapy. Proc Am Soc Clin Oncol. 1998; 17: 399a |
7 | Lamont EB, Vokes EE: Chemotherapy in the management of squamous-cell carcinoma of the head and neck. Lancet Oncol. 2001 ;2:261-269 DOI ScienceOn |
8 | Forastiere A, Koch W, Trotti A, Sidransky D: Head and neck cancer. N Engl J Med. 2001;345:1890-1900 DOI ScienceOn |
9 | Vokes EE, Weichelbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Eng J Med. 1993;21:184-194 |
10 | Lee JH, Lee KW, Choi YJ, et al. Docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinomas of the head and neck. Cancer Research and Treatment. 2003;35:261-266 DOI |
11 | Laramore GE, Scott CB, Al-sarraf M, et al: Adjuvant chemotherapy for respectable squamous cell carcinomas of the head and neck: report on intergroup study 0034. Int J Radiation Oncology Biol Physi. 1992;23:705-713 DOI ScienceOn |
12 | Schofski P, Catimel G, Planting AST, et al: Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group. Ann Oncol. 1999; 10: 119-122 DOI ScienceOn |
13 | The department of veterans affairs laryngeal cancer study group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324 (24):1685-1690 DOI ScienceOn |
14 | Amer MH, Al-sarraf M, Vaitkevicius VK: Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer. Cancer. 1979;43:2202-2206 DOI PUBMED ScienceOn |
15 | Catimel G, Verweij J, Mattijssen V, et al: Docetaxel (Taxotere): An active drug for treatment of patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol. 1994;5:533-537 DOI |
16 | Jacobs C, Goffinet DR, Goffinet L, Kohler M, Fee WE: Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the northern california oncology group. Cancer. 1987;60 (6) :1178-1183 DOI PUBMED ScienceOn |
17 | Lee GT, Byun JH, Hwangbo K, et all: Comparision of radiation therapy and combined chemotherapy and radiation therapy for locally advanced head and neck cancer. J Korean Cancer Assoc. 1997;29:616-622 |